NCT04886804 2026-03-13
Beamion LUNG-1: A Study to Test Different Doses of Zongertinib in People With Different Types of Advanced Cancer (Solid Tumours With Changes in the HER2 Gene)
Boehringer Ingelheim
Phase 1 Active not recruiting
Boehringer Ingelheim
Janssen Research & Development, LLC
Checkpoint Therapeutics, Inc.